Par Drugs and Chemicals (NSE:PAR) Institutional Ownership: 0.02% (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:PAR Par Drugs and Chemicals Ltd NSE:PAR
81 GF Score
Price ₹98.40
GF Value ₹208.32
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Par Drugs and Chemicals Institutional Ownership?

Par Drugs and Chemicals NSE:PAR -2.50% 81 Institutional Ownership is 0.02% as of Aug. 08, 2026. GuruFocus rates NSE:PAR with a GF Score™ of 81/100 and a GF Value™ of ₹208.32 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Par Drugs and Chemicals's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Par Drugs and Chemicals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Par Drugs and Chemicals's Float Percentage Of Total Shares Outstanding is 0.00%.

Par Drugs and Chemicals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Par Drugs and Chemicals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Par Drugs and Chemicals Institutional Ownership Chart

Par Drugs and Chemicals Historical Data

The historical data trend for Par Drugs and Chemicals can be seen below:

2025-02-28
Institutional Ownership 0.02
NSE:PAR
81GF Score
Par Drugs and Chemicals Ltd NSE:PAR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Par Drugs and Chemicals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.02% mean?
Par Drugs and Chemicals (NSE:PAR) has a Institutional Ownership of 0.02% as of Aug. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Par Drugs and Chemicals and its competitors.
Is Par Drugs and Chemicals' Institutional Ownership too high?
Par Drugs and Chemicals' current Institutional Ownership is 0.02%. Overall, Par Drugs and Chemicals has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Par Drugs and Chemicals' Institutional Ownership compare to ZTS?
Par Drugs and Chemicals' Institutional Ownership of 0.02% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Par Drugs and Chemicals and its competitors. Par Drugs and Chemicals's current Institutional Ownership is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Par Drugs and Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Par Drugs and Chemicals (NSE:PAR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹208.32, compared to a current price of ₹98.40 — trading 52.8% below its estimated fair value. The current Institutional Ownership is 0.02%. Par Drugs and Chemicals' overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Par Drugs and Chemicals (NSE:PAR), the current Institutional Ownership is 0.02% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Par Drugs and Chemicals (NSE:PAR) Overvalued in 2026?

Based on GuruFocus' analysis, Par Drugs and Chemicals stock appears to be undervalued. The current stock price of ₹98.40 is trading 52.8% below its estimated GF Value™ of ₹208.32. GuruFocus considers Par Drugs and Chemicals to be Significantly Undervalued.

Key valuation signals for NSE:PAR:

  • Institutional Ownership: 0.02%
  • GF Value™: ₹208.32 vs. price of ₹98.40 (52.8% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the NSE:PAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Par Drugs and Chemicals Business Description

Address Gotri Vasna Road, 815, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd manufactures active Pharmaceutical Ingredients (APIs) and fine chemicals, serving domestic and international markets. Specializing in essential magnesium-based compounds and other specialty chemicals such as Magnesium Hydroxide, Magnesium Trisilicate, Magnesium Carbonate, various grades of Magnesium Oxide, Dried Aluminum Hydroxide Gel, and Sucralfate USP, the Company produces high-quality bulk drugs used in the formulation of finished pharmaceutical products like tablets, capsules, and liquids. Committed to maintaining stringent quality standards and utilizing manufacturing processes, the Company plays a vital role in supplying reliable ingredients that ensure the safety, efficacy, and stability of pharmaceutical formulations internationally.
81GF Score

Get the complete analysis for NSE:PAR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.40
Price
₹208.32
GF Value